Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same
US-11510905-B1 · Nov 29, 2022 · US
Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections
US11872202B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11872202-B2 |
| Application number | US-202217695741-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 15, 2022 |
| Priority date | Dec 6, 2021 |
| Publication date | Jan 16, 2024 |
| Grant date | Jan 16, 2024 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I)R1, R2, R3, R4 and R5 are independently hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl or dimethylamino.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I): wherein R 1 , R 2 , R 3 , R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl, imidazolidine, and dimethylamino. 2. The pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections according to claim 1 , wherein the compound is selected from the group consisting of:
Assignees
Inventors
Classifications
- A61K31/216Primary
of acids having aromatic rings, e.g. benactizyne, clofibrate · CPC title
- A61P31/04Primary
Antibacterial agents · CPC title
- C07D233/56Primary
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms · CPC title
having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton · CPC title
of saturated acids · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11872202B2 cover?
- A pleuromutilin cinnamic acid ester compound with activities against antibiotic-resistant infections having the following formula (I)R1, R2, R3, R4 and R5 are independently hydrogen, halogen, nitro, cyano, methoxy, trifluoromethyl, benzyloxy, aryl or dimethylamino.
- Who is the assignee on this patent?
- Liang Chengyuan, Yang Xiuding, Xin Liang, and 8 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/216. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).